|
|
|
|
|
Detail |
| hsa-miR-155 |
|
Unspecified |
Accumulation of miR-155 and BIC RNA in human B cell lymphomas. |
2005 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Causal |
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. |
2006 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. |
2006 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
MicroRNAs play an essential role in the development of cardiac hypertrophy. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Expression profiling identifies microRNA signature in pancreatic cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
The role of microRNA genes in papillary thyroid carcinoma. |
2005 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
MicroRNA gene expression deregulation in human breast cancer. |
2005 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. |
2005 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Causal |
MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. |
2006 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Causal |
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. |
2005 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. |
2005 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. |
2004 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. |
2005 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Causal |
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. |
2006 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease |
2009 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Causal |
Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. |
2009 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
MicroRNA expression and identification of putative miRNA targets in ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Causal |
Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Causal |
MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
MicroRNA alterations in head and neck squamous cell carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
microRNA expression in the biology, prognosis and therapy of Waldenstrom macroglobulinemia. |
2009 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
The expression profile of microRNAs in a model of
7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. |
2009 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumours associates with poorer survival. |
2009 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumours associates with poorer survival. |
2009 |
|
|
|
|
|
|